Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope
Alejandrina Hernández-López, Mario A. Téllez-González, Mario A. Téllez-González et al. · Frontiers in Pharmacology · 2021
Abstract onlyNot checked
Pharmacology, Toxicology and Pharmaceutics: papers
Filters1 filter applied
7 papersQuestions on this topic
No paper holds every word you typed. These hold most of them.
Cancer metastasis chemoprevention prevents circulating tumour cells from germination
Xiaodong Xie, Yumei Li, Shu Lian et al. · Signal Transduction and Targeted Therapy · 2022
Abstract onlyNot checked
Advances in thiosemicarbazone metal complexes as anti-lung cancer agents
Xian-Guang Bai, Yunyun Zheng, Jinxu Qi · Frontiers in Pharmacology · 2022
Abstract onlyNot checked
Seatbelts in CAR therapy: How Safe Are CARS?
Kentaro Minagawa, Xiaoou Zhou, Shin Mineishi et al. · Pharmaceuticals · 2015
Abstract onlyNot checked
Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma
Yuan Lu, Jie Pan, Xiaoqing Zhu et al. · BMC Pharmacology and Toxicology · 2021
Abstract onlyNot checked
A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients
Reza Safaei Nodehi, Behjat Kalantari, Jahangir Raafat et al. · BMC Pharmacology and Toxicology · 2022
Abstract onlyNot checked
Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center
Milana Bergamino Sirvén, Adela Fernández-Ortega, Agostina Stradella et al. · BMC Pharmacology and Toxicology · 2019
Abstract onlyNot checked